Bradycardia and Blocks

CHAPTER


12


Bradycardia and Blocks


SINUS BRADYCARDIA AND SINOATRIAL (SA) NODE DYSFUNCTION


General Information


○Impairment of the sinoatrial (SA) node ability to generate propagated impulses


▪ Consider a 2:1 sinus exit block.


Epidemiology and Clinical Features


○Sinus bradycardia occurs in 1/600 patients over 65 years of age.


○Variable symptoms:


▪ Asymptomatic to fatigue, exercise intolerance, dyspnea, presyncope, or syncope.


▪ May lead to angina or heart failure.


○Often these patients are highly sensitive to cardiac medications (non-dihydropyridine calcium-channel blocker [ND-CCB], β-blockers, and antiarrhythmic drugs [AAD]).


○Frequently coexists with atrial tachyarrhythmia (atrial fibrillation [AF] and atrial flutter [AFL]).


Etiology


Intrinsic


○Degenerative: Idiopathic age-related fibrosis (most common)


▪ SA node fibrosis: Inappropriate sinus bradycardia and exaggerated overdrive suppression


▪ Atrial myocardial fibrosis: Propensity to AF or AFL


▪ Atrioventricular node (AVN) fibrosis: atrioventricular (AV) block


○Myocardial ischemia


▪ SA node: Supplied by right coronary artery (60%) or left circumflex artery (40%)


○Myocardial infiltration


▪ Sarcoidosis, amyloidosis, hemochromatosis


○Inflammatory


▪ Pericarditis, myocarditis


○Familial diseases


▪ Myotonic dystrophy, Friedrich ataxia, Na+ channel mutations


○Collagen vascular disease


▪ Systemic lupus erythematosus, rheumatoid arthritis, scleroderma, ankylosing spondylitis


○Trauma or surgery


▪ Valve replacement, ablation, atrial septal defect (ASD) repair, heart transplantation


Extrinsic


○Drugs


▪ AADs (class I, class III), β-blockers, diltiazem/verapamil, digoxin, ivabradine


▪ Sympatholytic (reserpine, methyldopa, clonidine), alcohol, lithium


○Electrolyte imbalances


▪ Potassium, calcium, or magnesium


○Metabolic


▪ Hypothyroidism, hypothermia


○Myocardial ischemia


▪ Inferior myocardial infarction (MI): Neural reflex


○Autonomic-mediated syndromes


▪ Neurocardiogenic syncope, carotid-sinus hypersensitivity


▪ Situational: Coughing, micturition, defecation, vomiting


○Infection


▪ Chagas, endocarditis, Salmonella, diphtheria, rheumatic fever, viral myocarditis


Classification


○ Inappropriate sinus bradycardia


▪ Sinus bradycardia in the absence of an appropriate cause or that results in symptoms


○ Tachycardia-bradycardia syndrome


▪ Atrial tachycardia (AT; usually AF) alternating with sinus bradycardia, sinus pauses, and/or an AV block


○ Intermittent sinus pauses include:


▪ Sinus arrest: Transient cessation of SA node firing (>2 seconds)


▪ Sinoatrial (SA) exit block: Depolarization fails to exit the SA node (the RR interval is unchanged).


• Type 1 (Mobitz): The time between sinus firing and when the atrial capture progressively prolongs leading to gradual shortening in the PP intervals before the pause (pause PP < two preceding PP).


• Type 2 (Mobitz): The PP interval is constant before and after the pause and is a multiple (2×, 3×…) of the basic PP interval.


○ Chronotropic incompetence: Inappropriately low heart rate response during exercise.


▪ Absolute: Inability to increase heart rate to 60% age-predicted target (220 – age) or to >100–120 bpm.


▪ Relative: Able to reach target heart rate but at a significant delay with reduced exercise tolerance.


12-Lead ECG


image


○Heart rate <60 bpm with characteristics of sinus rhythm


▪ 1:1 P:QRS relationship


• Every P wave is followed by a QRS complex and every QRS complex is preceded by a P wave.


▪ Sinus P-wave morphology and axis


• Upright in I, II, aVF, and V2–V6 (best seen in II)


• Inverted in aVR


• Upright or biphasic in V1 and V2; upright in V3–V6


Other Investigations


○Carotid sinus massage or tilt table testing to identify neurocardiogenic causes


○Treadmill stress test


▪ Assesses the chronotropic response to exercise


○Ambulatory electrocardiogram (ECG) monitoring (Holter, event monitor, ILR)


▪ Correlates symptoms with the electrical disorder


○Assessment of intrinsic heart rate (IHR: Rarely performed)


▪ IV atropine 0.04 mg/kg + IV propranolol 0.2 mg/kg


▪ Predicted IHR = 118.1 – [0.57 × age]:


• Low IHR = intrinsic sinus node dysfunction (SND)


• Normal IHR = autonomic imbalance


○Electrophysiology study (see Assessment of SA Node Function section)


Management


Acute Management


○Atropine or isoproterenol


Chronic Management


○Stop medications that suppress the SA node (e.g., β-blockers, verapamil/diltiazem, digoxin).


○Pacemaker indications:


▪

Stay updated, free articles. Join our Telegram channel

Feb 28, 2017 | Posted by in CARDIOLOGY | Comments Off on Bradycardia and Blocks

Full access? Get Clinical Tree

Get Clinical Tree app for offline access